Premium
Survival of NobelDirect Implants: An Analysis of 550 Consecutively Placed Implants at 18 Different Clinical Centers
Author(s) -
Albrektsson Tomas,
Gottlow Jan,
Meirelles Luiz,
Östman PerOlov,
Rocci Antonio,
Sennerby Lars
Publication year - 2007
Publication title -
clinical implant dentistry and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.338
H-Index - 85
eISSN - 1708-8208
pISSN - 1523-0899
DOI - 10.1111/j.1708-8208.2007.00054.x
Subject(s) - implant , dentistry , medicine , survival rate , multicenter study , bone resorption , implant failure , surgery , randomized controlled trial
Background: A recently introduced implant, the NobelDirect (Nobel Biocare AB, Göteborg, Sweden), has previously been documented with substantial bone resorption in a large number of operated cases. PurposeL The aim of this study was to evaluate the failure rate of NobelDirect implants in a retrospective multicenter survey. Materials and Methods: A total of 550 NobelDirect implants consecutively placed in over 269 patients at 18 centers were evaluated with regard to failure rate after an average follow‐up of about 1 year. Results: The overall failure percentage was 10.9% (59 failures). The 58 implants not loaded directly showed only one failure (1.7%) versus 58 failures (11.8%) of those implants that were loaded directly. A chemical x‐ray photoelectron spectroscopy analysis of an implant from the original batch showed up to 3.5% silicon at parts of the implants. A retrieval analysis of one implant removed at 2 years after placement demonstrated bone resorption down to the level of the fifth thread. Conclusions: It is concluded that the NobelDirect implant, if placed with a punch procedure, ground down in situ, and loaded directly, shows an unusually high failure rate at 1 year.